Clinical Trial Update: Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating a novel quadruple combination therapy (mifepristone, tamoxifen, retinoic acid, cannabidiol selective CYP26 inhibitor) for e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Cannabidiol (cannabidiol)
• Mifepristone (mifepristone)
• Retinoic acid (all-trans retinoic acid)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Mahmoud Ramadan mohamed Elkazzaz | Conditions: Breast Cancer Female | Phase 3 | Status: UNKNOWN